BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  Biomolecular Atlas for Bone Marrow to Offer Unprecedented Window into Blood Production

  Researchers at Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania revealed a powerful new bone marrow atlas that will offer the public a first-of-its-kind visual passport into the spectrum of healthy and diseased blood production.

  May 6, 2024

   · 

  5 min read
• Press Releases

  Sana Biotechnology to Present at May and June 2024 Investor Conferences

  Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at three investor conferences in May and June.

  May 6, 2024

   · 

  3 min read
• Business

  ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates

  ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today reported financial results and operational updates for the quarter ended March 31, 2024.

  May 6, 2024

   · 

  9 min read
• Business

  Shockwave Medical Reports First Quarter 2024 Financial Results

  Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months ended March 31, 2024.

  May 6, 2024

   · 

  9 min read
• Biotech Beach

  Telesis Bio Announces Reverse Stock Split - May 06, 2024

  Telesis Bio Inc., a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid automated synthesis in their own lab, announced that it will effect a 1-for-18 reverse stock split of its common stock.

  May 6, 2024

   · 

  4 min read
• Pharm Country

  Regeneron Announces Investor Conference Presentations - May 06, 2024

  Regeneron Pharmaceuticals, Inc. will webcast management participation as follows.

  May 6, 2024

   · 

  1 min read
• Business

  Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update

  Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported financial results for the first quarter ended March 31, 2024 and provided a corporate update.

  May 6, 2024

   · 

  11 min read
• Business

  Assertio Reports First Quarter 2024 Financial Results

  Assertio Holdings, Inc., a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, reported financial results for the first quarter ended March 31, 2024.

  May 6, 2024

   · 

  20 min read
• Business

  FibroGen Reports First Quarter 2024 Financial Results

  FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the first quarter 2024 and provided an update on the company’s recent developments.

  May 6, 2024

   · 

  11 min read
• Business

  RxSight, Inc. Reports First Quarter 2024 Financial Results

  RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, reported financial results for the three months ended March 31, 2024.

  May 6, 2024

   · 

  10 min read